🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Utility of PCD Diagnostics to Improve Clinical Care

RecruitingNAAges 1 Year - anyAllVanderbilt University Medical Center
NCT03704207 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Referred to center for PCD diagnosis considerations * Ability to perform study procedures * Age greater than 2 years of age Exclusion Criteria: * Age less than 2 years of age Inability to perform informed consent
💊

What it tests

  • nNO testing
📍

Where

1 site
Vanderbilt Children's hospital
Nashville, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy